The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Manoj Sunil Chawda
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Manoj Sunil Chawda, part of the promoter group of Oxygenta Pharmaceutical Limited, has sold 10,12,800 equity shares (2.74% of the company's voting capital) through a Share Purchase Agreement dated September 30, 2024, with the transaction completed on April 22, 2025. Following this sale, his holding has dropped from 15,82,500 shares (4.28%) to 5,69,700 shares (1.54%) of the company. The shares are listed on BSE (Scrip Code: 524636), and the total equity share capital remains unchanged at 3,69,83,500 shares of Rs. 10 each. No encumbrances, warrants, or convertible securities are involved in this transaction.
This is a notable promoter exit, with the promoter group member reducing his stake by more than half. For shareholders, this signals continued promoter selling and may raise concerns about insider confidence in the stock, potentially putting short-term pressure on the share price.